Skip to main content
Livermore
Livermore
ZHEN

Vestor Capital, LLC

SEC CIK
0001132699
Latest filing
Jul 28, 2026

The latest 13F from Vestor Capital, LLC covers Q2 2026 (filed Jul 28, 2026): 276 long positions worth $1.18B. The top 10 holdings make up 46.2% of the portfolio, and the largest is Krystal Biotech, Inc. (KRYS) at 6.6%. Livermore has 26 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
41
Est. +$77.2M
Added
127
Est. +$918.3M
Reduced
107
Est. −$2.36B
Sold out
41
Est. −$70.4M

Top 5 holdings

Share of this quarter's portfolio value

  1. KRYSKrystal Biotech, Inc.
    6.6%$78.2MHistory
  2. ORCLOracle Corp
    6.4%$76.0MHistory
  3. AXPAmerican Express Co
    5.4%$64.1MHistory
  4. JNJJohnson & Johnson
    4.5%$53.5MHistory
  5. NFGNational Fuel Gas Co
    4.4%$51.6MHistory

Share of portfolio

Top 5 holdings and the other 271 positions, by share of portfolio value

  1. KRYS6.6%
  2. ORCL6.4%
  3. AXP5.4%
  4. JNJ4.5%
  5. NFG4.4%
  6. Other 271 positions72.6%

Biggest buys

New and added positions, by estimated amount bought

  1. KRYSKrystal Biotech, Inc.
    +$78.2MAddedHistory
  2. ORCLOracle Corp
    +$73.8MAddedHistory
  3. AXPAmerican Express Co
    +$63.8MAddedHistory
  4. JNJJohnson & Johnson
    +$51.6MAddedHistory
  5. NFGNational Fuel Gas Co
    +$51.5MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. KRYSKrystal Biotech, Inc.
    +6.62 pp<0.1% → 6.6%History
  2. ORCLOracle Corp
    +6.32 pp0.1% → 6.4%History
  3. AXPAmerican Express Co
    +5.42 pp<0.1% → 5.4%History
  4. JNJJohnson & Johnson
    +4.49 pp<0.1% → 4.5%History
  5. NFGNational Fuel Gas Co
    +4.37 pp<0.1% → 4.4%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. CATXPerspective Therapeutics, Inc.
    −$1.08BReducedHistory
  2. JUNSJupiter Neurosciences, Inc.
    −$246.1MReducedHistory
  3. State Street Industrial Select Sector SPDR ETF81369Y704
    −$163.9MReduced
  4. AAPLApple Inc.
    −$111.6MReducedHistory
  5. GOOGAlphabet Inc.
    −$92.1MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. AAPLApple Inc.
    −6.06 pp6.1% → <0.1%History
  2. State Street Energy Select Sector SPDR ETF81369Y506
    −4.48 pp4.5% → 0.0%
  3. NVDANVIDIA Corp
    −3.95 pp4.0% → <0.1%History
  4. State Street Industrial Select Sector SPDR ETF81369Y704
    −3.54 pp3.7% → 0.2%
  5. JPMJPMorgan Chase & Co
    −3.27 pp3.8% → 0.6%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$1.18B
−$201.6M (−14.6%) vs. prior quarter
Positions
276
0 vs. prior quarter
Top 10 concentration
46.2%
Top 10 as share of value
Turnover
77.7%
Q2 2026, one quarter
Average holding period
14.8 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $1.56B (Q3 2025)

Q1 2021: $875.3MQ2 2021: $952.6MQ3 2021: $958.4MQ4 2021: $1.05BQ1 2022: $1.01BQ2 2022: $824.8MQ3 2022: $762.5MQ4 2022: $829.2MQ1 2023: $850.8MQ2 2023: $948.5MQ3 2023: $921.4MQ4 2023: $1.05BQ1 2024: $1.18BQ2 2024: $1.24BQ3 2024: $1.27BQ4 2024: $1.31BQ1 2025: $1.22BQ2 2025: $1.03BQ3 2025: $1.56BQ4 2025: $1.37BQ1 2026: $1.38BQ2 2026: $1.18B
Q1 2021Q2 2026
13F filings of Vestor Capital, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 28, 2026276$1.18BKRYSORCLAXPvs. Q1 2026SEC
Q1 2026May 21, 2026276$1.38BAAPLState Street Energy Select Sector SPDR ETFNVDAvs. Q4 2025SEC
Q4 2025Feb 11, 2026265$1.37BGOOGAAPLMSFTvs. Q3 2025SEC
Q3 2025Nov 13, 2025288$1.56BGOOGAAPLAVGOvs. Q2 2025SEC
Q2 2025Aug 12, 2025274$1.03BABBVAMDAFRMvs. Q1 2025SEC
Q1 2025May 6, 2025253$1.22BState Street Financial Select Sector SPDR ETFAAPLMETAvs. Q4 2024SEC
Q4 2024Feb 11, 2025273$1.31BAAPLMSFTNVDAvs. Q3 2024SEC
Q3 2024Oct 29, 2024245$1.27BAAPLMSFTNVDAvs. Q2 2024SEC
Q2 2024Jul 30, 2024245$1.24BAAPLMSFTNVDAvs. Q1 2024SEC
Q1 2024May 14, 2024255$1.18BMSFTNVDAMETAvs. Q4 2023SEC
Q4 2023Feb 14, 2024Amended239$1.05BAAPLMSFTAMZNvs. Q3 2023SEC
Q3 2023Nov 8, 2023244$921.4MAAPLMSFTMETAvs. Q2 2023SEC
Q2 2023Aug 21, 2023Amended262$948.5MAAPLMSFTMETAvs. Q1 2023SEC
Q1 2023May 10, 2023Amended242$850.8MAAPLMSFTSLBvs. Q4 2022SEC
Q4 2022Feb 13, 2023234$829.2MAAPLSLBUNHvs. Q3 2022SEC
Q3 2022Nov 14, 2022217$762.5MAAPLMSFTUNHvs. Q2 2022SEC
Q2 2022Aug 10, 2022209$824.8MAAPLMSFTUNHvs. Q1 2022SEC
Q1 2022May 9, 2022230$1.01BAAPLMSFTGOOGvs. Q4 2021SEC
Q4 2021Feb 11, 2022233$1.05BAAPLMSFTGOOGvs. Q3 2021SEC
Q3 2021Nov 15, 2021236$958.4MAAPLMSFTJPMvs. Q2 2021SEC
Q2 2021Aug 13, 2021215$952.6MAAPLMSFTJPMvs. Q1 2021SEC
Q1 2021May 14, 2021209$875.3MAAPLMSFTJPM–SEC